Cutaneous T cell lymphoma (CTCL) is a class of non-Hodgkin lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin lymphomas (which are generally B cell related), CTCL is caused by a mutation of T cells. The malignant T cells in the body initially migrate to the skin, causing various lesions to appear. These lesions change shape as the disease progresses, typically beginning as what appears to be a rash which can be very itchy and eventually forming plaques and tumors before metastasizing to other parts of the body.
Classification
Cutaneous T-cell lymphomas may be divided into the following types:
"Cutaneous T-Cell Lymphoma (CTCL) Treatment Market" ... In 2023, the total CTCL market size was around USD 520 million, which is expected to increase by 2034 during the study period (2020–2034) in the 7MM.